Medication info
Amosartan XQ Tablet 5/50/10/10 Milligrams

Amosartan XQ Tablet 5/50/10/10 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tabletEzetimibe›10mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Pale yellow oval film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP×3]
Approval status
Active

MFDS item code 202007693 · Approved 2020.11.09 · Insurance code 643508360

Summary

Main use
Treatment of hypertension and dyslipidemia (hypercholesterolemia, etc.)
Who takes it
Adults
Adult dose
This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow the tablet whole without chewing, dividing, or crushing it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/losartan combination may be considered as follows. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the anticipated likelihood of achieving the treatment goal with the combination compared with a single agent. The usual dose is amlodipine/losartan 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: Dose adjustment is not required in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older adults: In older adults aged 75 years or over, an initial losartan dose of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10 mg to 20/10 mg once daily. The recommended initial dose is 5/10 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10 mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia (hypercholesterolemia, etc.)

  • Essential hypertension
  • stage 2 hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used for patients who need to take a combination of amlodipine and losartan, and rosuvastatin and ezetimibe simultaneously. It mainly helps patients whose essential hypertension is not adequately controlled or those with stage 2 hypertension at initial treatment. Additionally, it is used to improve cholesterol and triglyceride levels in patients with primary hypercholesterolemia or dyslipidemia. This medication should be taken in conjunction with a diet, and prior causes should be verified and treated before use if there are any secondary causes. It helps effectively control the patient's blood pressure and lipid levels, thus reducing the risk of cardiovascular diseases. Therefore, it is very useful for the treatment of hypertension and dyslipidemia.

How to take

Adult dose

This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/losartan combination and the rosuvastatin/ezetimibe combination. The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Swallow the tablet whole without chewing, dividing, or crushing it. ○ Amlodipine/losartan combination The recommended dose of the amlodipine/losartan combination is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering the amlodipine/losartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/losartan combination may be considered as follows. - 5/50 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Before administering the amlodipine/losartan combination as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the anticipated likelihood of achieving the treatment goal with the combination compared with a single agent. The usual dose is amlodipine/losartan 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ∘ Patients with renal impairment: Dose adjustment is not required in patients with mild renal impairment; however, use of the amlodipine/losartan combination is not recommended in patients with moderate renal impairment. ∘ Patients with reduced intravascular volume: Use of the amlodipine/losartan combination is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of the amlodipine/losartan combination is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ∘ Older adults: In older adults aged 75 years or over, an initial losartan dose of 25 mg once daily is recommended; therefore, use of the amlodipine/losartan combination as initial therapy is not recommended. ○ Rosuvastatin/ezetimibe combination The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dosage range of the rosuvastatin/ezetimibe combination is 5/10 mg to 20/10 mg once daily. The recommended initial dose is 5/10 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10 mg once daily. Patients taking the amlodipine/losartan combination together with the rosuvastatin/ezetimibe combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication can cause serious harm to the fetus and newborn during pregnancy; therefore, it must be discontinued immediately upon confirmation of pregnancy. Hypotension may occur upon initial administration to patients with reduced blood volume, so such patients should stabilize their condition prior to taking this medication. Patients at risk for muscle-related disorders must report any symptoms of muscle pain or weakness to their doctor immediately, and discontinue use if necessary. Those with allergies to the components of this medication or specific liver or kidney diseases should not take it. Caution is necessary for elderly patients or those with hypotension, hyperkalemia, and heart valve diseases, and regular examinations are required. Patients with liver or kidney issues must have regular liver and kidney function tests prior to and during use of this medication. This medication carries a risk of muscle damage, so patients who typically experience muscle pain or weakness should consult their doctor. There is a possibility of drug interactions; therefore, any concurrent medications should be reported, especially when taken along with antihypertensives, lipid-lowering agents, anticoagulants, etc. Caution is required when driving or operating machinery as dizziness may occur. This medication contains lactose and should not be taken by patients with lactose intolerance. If any abnormal symptoms or suspected side effects occur while taking this medication, immediate consultation with medical staff is necessary.

Side effects

Decreased cranial formation, anuria, hypotension, renal failure, elevated ALT, elevated AST, dermatitis, positional dizziness, global ischemia, rhabdomyolysis, pancreatic carcinoma, facial edema, unusual sensation, drug intolerance, colonic polyps, irritable bowel syndrome, esophagitis, dizziness, drowsiness, neurodegenerative disorders, migraine, diabetes, glucose tolerance disorders, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver disorders, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, facial swelling, fever, orthostatic effects, syncope, angina pectoris, second-degree atrioventricular block, cerebrovascular accident, hypotension, myocardial infarction, atrial fibrillation, palpitations, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, decreased appetite, constipation, dental pain, dry mouth, flatulence, gastritis, vomiting, anemia, gout, upper limb pain, hip joint pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscle rigidity, arthralgia, arthritis, fibromyalgia, myasthenia, anxiety, anxiety disorders, ataxia, confusion, nightmares, sensory disturbances, decreased libido, memory impairment, neuroexcitability, sensory abnormalities, peripheral neuropathy, panic disorder, sleep disturbances, tremors, dyspnea, bronchitis, pharyngeal discomfort, epistaxis, rhinitis, respiratory congestion, chest discomfort, hair loss, dermatitis, dry skin, petechiae, erythema, flushing, photosensitivity reactions, itching, rash, sweating, hives, blurred vision, burning and stabbing sensation in the eyes, conjunctivitis, taste disturbances, tinnitus, vision impairment, erectile dysfunction, nocturia, frequent urination, urethral infection, benign esophageal neoplasm, angioedema, vasculitis, anaphylactoid syndrome, liver function abnormalities, intestinal vascular edema, fatigue, thrombocytopenia, myalgia, weakness, elevated creatine kinase, increased myoglobin in blood and urine, taste disturbances, dry cough, erythema multiforme, hyperkalemia, hyponatremia, syncope, loss of consciousness, acute hepatitis, fulminant hepatitis, ventricular extrasystole, hypoglycemia, weakness, hunger, sweating, tremors, concentration impairment, convulsions, altered consciousness, headache, fatigue, edema, palpitations, dizziness, drowsiness, abdominal pain, nausea, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, hypertension, sensory reduction, sensory abnormalities, peripheral neuropathy, syncope, taste disturbances, tremors, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, hair loss, increased sweating, purpura, skin discoloration, hives, toxic epidermal necrolysis, auditory disturbances, visual disturbances, increased urinary frequency, urination difficulties, nocturia, hepatitis, jaundice, elevated liver enzyme levels, hypotension due to reduced effective blood volume, increased serum creatinine, increased blood pressure, elevated blood urea, increased blood creatine phosphokinase, abnormal liver function tests, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, immune-mediated necrotizing myopathy, amnesia, polyneuropathy, peripheral neuropathy, diarrhea, jaundice, hepatitis, cholelithiasis, cholecystitis, upper respiratory tract infections, conjunctival congestion, renal failure, liver function abnormalities, generalized pain, muscle cramps, gout

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. This helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Pale yellow oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.